BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27356643)

  • 1. [Clinical analysis of Sweet syndrome with myelodysplasia syndrome].
    Wang YN; Zhuang JL; Zhao WL; Fang K; Liu YH; Jin HZ; Li L
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1755-7. PubMed ID: 27356643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweet's syndrome evolved from recurrent erythema nodosum in a patient with myelodysplastic syndrome.
    Nishie W; Kimura T; Kanagawa M
    J Dermatol; 2002 Feb; 29(2):91-5. PubMed ID: 11890302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthomatized Neutrophilic Dermatosis in a Patient With Myelodysplastic Syndrome.
    Ferris GJ; Fabbro S; Gru A; Kaffenberger J
    Am J Dermatopathol; 2017 May; 39(5):384-387. PubMed ID: 27759696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of neutrophilic dermatosis (ND) complicated by cryofibrinogenemia (CFGN) and myelodysplastic syndrome (MDS).
    Watanabe R; Iijima M; Otsuka F
    J Dermatol; 1992 Mar; 19(3):181-5. PubMed ID: 1640024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
    Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.
    Lin CH; Yeh SP; Lin TY
    Ann Hematol; 2015 Nov; 94(11):1925-6. PubMed ID: 26233682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Successful treatment of an essential thrombocythemia patient complicated by Sweet's syndrome with combination of chemotherapy and lenalidomide].
    Yamada M; Kuroda H; Yoshida M; Jomen W; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Matsuno T; Sato M; Kato J
    Rinsho Ketsueki; 2014 Apr; 55(4):440-4. PubMed ID: 24850455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome.
    Oka S; Ono K; Nohgawa M
    Intern Med; 2018 Feb; 57(4):595-600. PubMed ID: 29225251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweet syndrome: a painful reality.
    Khan U; Rizvi H; Ali F; Lebovic D
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28011887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases.
    Vignon-Pennamen MD; Juillard C; Rybojad M; Wallach D; Daniel MT; Morel P; Verola O; Janin A
    Arch Dermatol; 2006 Sep; 142(9):1170-6. PubMed ID: 16983004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of Sweet's syndrome with extensive necrosis and ulcers accompanied by myelodysplastic syndrome.
    Kato T; Kawana S; Takezaki S; Kikuchi S; Futagami A
    J Nippon Med Sch; 2008 Jun; 75(3):162-5. PubMed ID: 18648174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweet's syndrome and myelodysplasia: two entities with a common pathogenetic mechanism? A case report.
    Zappasodi P; Corso A; del Forno C
    Haematologica; 2000 Aug; 85(8):868-9. PubMed ID: 10942935
    [No Abstract]   [Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet's syndrome associated with recurrent fever in a patient with trisomy 8 myelodysplastic syndrome.
    Hattori H; Hoshida S; Yoneda S
    Int J Hematol; 2003 May; 77(4):383-6. PubMed ID: 12774928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
    del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
    Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of recurrent Sweet's syndrome in an 80-year-old man: a clue to an underlying malignancy.
    Choi HJ; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    Int J Dermatol; 2006 Apr; 45(4):457-9. PubMed ID: 16650178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
    Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of bicytopenia and pancytopenia during pregnancy].
    Zhang C; Liang MY; Wang SM
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):488-91. PubMed ID: 19957545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia.
    Browning CE; Dixon JE; Malone JC; Callen JP
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S135-8. PubMed ID: 16021163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndrome with neutrophilic dermatosis successfully treated with azacitidine].
    Kudo D; Shimizu M; Kuroda A; Suyama T; Shinagawa A; Ito S
    Rinsho Ketsueki; 2017; 58(6):607-612. PubMed ID: 28679990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.